Arkolith/Insider Trading/GWPH/Form 4

Waldegrave William A.

DirectorGW PHARMACEUTICALS PLC (GWPH) · full profile →Form 4 · filed May 7, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 5, 2021Disposed to issuer(D)34K——0
May 5, 2021Disposed to issuer(D)9K——0
May 5, 2021Disposed to issuer(D)17K——0
May 5, 2021Disposed to issuer(D)7K——0
May 5, 2021Disposed to issuer(D)35K——0
May 5, 2021Disposed to issuer(D)22K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-018657) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML